Results 151 to 160 of about 2,131,145 (306)

Health promotion 4.0 [PDF]

Health Promotion International, 2019
openaire   +2 more sources

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Achieving the Millennium Development Goals : The role of infrastructure [PDF]

The authors provide an empirical analysis of the determinants of three child-health outcomes related to the Millennium Development Goals: the infant mortality rate, the child mortality rate, and the prevalence of malnutrition. Using data from Demographic
Danny Leipziger, Marianne Fay, Quentin Wodon, Tito Yepes   +3 more
core  

Re-storying health promotion models toward population sovereignty. [PDF]

Front Public Health
Olson K, Erb M, Si'al E, Piechowski A, Riegert J, Ranjbar N.   +5 more
europepmc   +1 more source

Workplace Health Promotion

Industrial Health, 2010
Takashi, Muto, Toshiaki, Higashi
openaire   +3 more sources

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

Twenty-Two Health Promotion Pioneers. [PDF]

, 2015
Anderson, David R, Burton, Wayne N, Eng, Eugenia, Goetzel, Ron Z, Green, Larry, Hunnicutt, David, Israel, Barbara, Katz, David, Linnan, Laura, Loeppke, Ron, Minkler, Meredith, Palma-Davis, LaVaughn, Parker, Edith, Pasick, Rena J, Pronk, Nicolaas P, Resnicow, Ken, Schulz, Amy J, Serxner, Seth, Strecher, Victor J, Terry, Paul E, Wallerstein, Nina, Whitsel, Laurie   +21 more
core  

Middle-range theory for men's health promotion: contributions to sustainable development. [PDF]

Rev Bras Enferm
Rosa ITM, Corrêa ACP, Félix NDC, Oliveira JCAX.   +3 more
europepmc   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Participatory Action Research in Health Promotion in the Philippines: A Scoping Review. [PDF]

Acta Med Philipp
Famaloan FRAN, Alvina KC, Ong LAD, Antonio CAT, Reyes KAV.   +4 more
europepmc   +1 more source